ES2132087T3 - Plasmidios que contienen adn que codifica la secuencia de aminoacidos de tcf-ii, celulas transformadas y produccion de la sustancia fisiologicamente activa usando las mismas. - Google Patents
Plasmidios que contienen adn que codifica la secuencia de aminoacidos de tcf-ii, celulas transformadas y produccion de la sustancia fisiologicamente activa usando las mismas.Info
- Publication number
- ES2132087T3 ES2132087T3 ES91912323T ES91912323T ES2132087T3 ES 2132087 T3 ES2132087 T3 ES 2132087T3 ES 91912323 T ES91912323 T ES 91912323T ES 91912323 T ES91912323 T ES 91912323T ES 2132087 T3 ES2132087 T3 ES 2132087T3
- Authority
- ES
- Spain
- Prior art keywords
- tcf
- complementary dna
- plasmide
- transformed cells
- codes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 239000013543 active substance Substances 0.000 title 1
- 239000013612 plasmid Substances 0.000 title 1
- 108020004635 Complementary DNA Proteins 0.000 abstract 4
- 238000010804 cDNA synthesis Methods 0.000 abstract 4
- 239000002299 complementary DNA Substances 0.000 abstract 4
- 108020005187 Oligonucleotide Probes Proteins 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000010261 cell growth Effects 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 210000003754 fetus Anatomy 0.000 abstract 1
- 239000003102 growth factor Substances 0.000 abstract 1
- 210000003494 hepatocyte Anatomy 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 239000002751 oligonucleotide probe Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
- 210000004881 tumor cell Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4753—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
SE PREPARA UNA BIBLIOTECA DE ADN COMPLEMENTARIO EXTRAYENDO LA TOTALIDAD DE ARN MENSAJERO DE FIBROBLASTOS DE PULMON DE FETO HUMANO. DE ESTA BIBLIOTECA SE CLONA UN ADN COMPLEMENTARIO QUE CODIFICA TCF-II A LO LARGO DE TODA SU LONGITUD UTILIZANDO UNA SONDA DE OLIGONUCLEOTIDO SINTETICA QUE CODIFICA UN AMINOACIDO TERMINAL N, Y SE DETERMINA TODA LA SECUENCIA BASE DEL ADN COMPLEMENTARIO. SE EXPRESA UNA GRAN CANTIDAD DE TCF-II EN CELULAS DE MAMIFERO TRANSFORMADAS MEDIANTE PLASMIDA QUE CONTIENE EL ADN COMPLEMENTARIO Y SE PURIFICA EL TCF-II ASI DERIVADO DE LAS CELULAS TRANSFORMADAS. EL TCF-II PURIFICADO ES UTIL COMO FACTOR DE CRECIMIENTO DE CELULA HEPATICA O FACTOR ACTIVO DE DESTRUCCION DE CELULA TUMORAL EN EL CAMPO MEDICO O SIMILAR. A... PLASMIDA QUE EXPRESA TCF-II B... PROMOTOR CNV/T7 C... SELECCION PF D... PUNTO DE INICIACION DE REPLICACION E... SEÑAL DE UNION MAS SEÑAL DE POLI (A) ADICION F... TRATAMIENTO DE TERMINAL LISO SEGUN KLENOV G... PLASMIDA QUE EXPRESA TCF-II EN GRAN CANTIDAD
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18585290 | 1990-07-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2132087T3 true ES2132087T3 (es) | 1999-08-16 |
Family
ID=16178009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91912323T Expired - Lifetime ES2132087T3 (es) | 1990-07-13 | 1991-07-15 | Plasmidios que contienen adn que codifica la secuencia de aminoacidos de tcf-ii, celulas transformadas y produccion de la sustancia fisiologicamente activa usando las mismas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5328836A (es) |
EP (1) | EP0539590B1 (es) |
JP (1) | JP2634323B2 (es) |
KR (1) | KR0153009B1 (es) |
AT (1) | ATE178354T1 (es) |
CA (1) | CA2066618C (es) |
DE (1) | DE69131069T2 (es) |
DK (1) | DK0539590T3 (es) |
ES (1) | ES2132087T3 (es) |
WO (1) | WO1992001053A1 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ232813A (en) * | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
US5821223A (en) * | 1990-09-14 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method of stimulating cell growth with a novel broad spectrum human lung fibroblast-derived mitogen |
DE69230879T2 (de) * | 1991-07-26 | 2000-08-03 | Toray Industries, Inc. | Verwendung von Hepatocyten-Wachstumsfaktoren zur Herstellung eines Vermehrungssystems für Hematopoietische Stammzellen |
WO1993023541A1 (en) * | 1992-05-18 | 1993-11-25 | Genentech, Inc. | Hepatocyte growth factor variants |
US5328837A (en) * | 1992-05-18 | 1994-07-12 | Genentech, Inc. | Hepatocyte growth factor protease domain variants |
US5316921A (en) * | 1992-05-18 | 1994-05-31 | Genentech, Inc. | Single-chain hepatocyte growth factor variants |
CA2140010C (en) * | 1992-07-16 | 2008-04-01 | Hiroaki Masunaga | Blood coagulation normalizer containing tcf-ii as active ingredient |
ES2276409T3 (es) | 1992-07-16 | 2007-06-16 | Daiichi Pharmaceutical Co., Ltd. | Composicion medica que contiene tcf-ii. |
JP3402476B2 (ja) * | 1992-08-24 | 2003-05-06 | 生化学工業株式会社 | リポ多糖結合性タンパク質及びその製造法 |
JP3552240B2 (ja) * | 1993-02-23 | 2004-08-11 | 第一製薬株式会社 | 高濃度tcf製剤 |
IT1271088B (it) * | 1994-11-24 | 1997-05-26 | Dompe Spa | Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche |
NZ298142A (en) * | 1994-12-27 | 1997-08-22 | Snow Brand Milk Products Co Ltd | Tcf mutant |
KR19980020025A (ko) * | 1996-09-05 | 1998-06-25 | 김종진 | 미생물을 이용한 폐수중의 나프탈렌 제거 방법 |
JP4006058B2 (ja) | 1997-03-11 | 2007-11-14 | 第一三共株式会社 | 多臓器不全予防及び/又は治療剤 |
WO1998041230A1 (fr) | 1997-03-14 | 1998-09-24 | Snow Brand Milk Products Co., Ltd. | Agent preventif et/ou curatif de la cachexie |
KR100562824B1 (ko) * | 2002-03-20 | 2006-03-23 | 주식회사 바이로메드 | 유전자 발현효율이 높으며 간세포 성장인자의 두 가지이형체를 동시에 발현하는 하이브리드 간세포 성장인자유전자 |
EP1814575A4 (en) * | 2004-11-24 | 2010-07-07 | Neopro Labs Llc | METHODS AND COMPOSITIONS FOR TREATING DISORDERS |
US7557088B2 (en) * | 2006-03-28 | 2009-07-07 | Neopro Labs, Llc | Methods and compositions for treating conditions |
WO2008144675A1 (en) | 2007-05-17 | 2008-11-27 | Neopro Labs, Llc | Crystalline and amorphous forms of peptide |
WO2009012472A2 (en) * | 2007-07-18 | 2009-01-22 | Neopro Labs, Llc | Methods and compositions for treating conditions |
US20090202606A1 (en) * | 2008-01-25 | 2009-08-13 | Viromed Co., Ltd. | Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor |
RU2470995C2 (ru) * | 2008-04-09 | 2012-12-27 | Вайромед Ко., Лтд. | Лиофилизированные днк-составы для увеличенной экспрессии плазмидной днк |
AU2014337870B2 (en) | 2013-10-22 | 2019-11-28 | Helixmith Co., Ltd. | Composition for preventing or treating amyotrophic lateral sclerosis using two or more isoforms of hepatocyte growth factor |
EP3823677A4 (en) | 2018-07-19 | 2022-06-01 | Helixmith Co., Ltd. | FREEZE-DRIED PHARMACEUTICAL COMPOSITIONS INTENDED FOR NAKED-DNA GENE THERAPY |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62171696A (ja) * | 1986-01-23 | 1987-07-28 | Sumitomo Chem Co Ltd | ヒトエリスロポエチンの製造方法 |
NZ232813A (en) * | 1989-03-10 | 1992-08-26 | Snow Brand Milk Products Co Ltd | Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons |
CA2022752C (en) * | 1989-08-11 | 1998-07-07 | Naomi Kitamura | Hepatic parenchymal cell growth factor, gene encoding the same, process for producing the factor, and transformants producing the factor |
JP2777678B2 (ja) * | 1990-06-11 | 1998-07-23 | 敏一 中村 | 組換ヒト肝実質細胞増殖因子及びその製造方法 |
-
1991
- 1991-07-15 AT AT91912323T patent/ATE178354T1/de not_active IP Right Cessation
- 1991-07-15 JP JP3511690A patent/JP2634323B2/ja not_active Expired - Fee Related
- 1991-07-15 US US07/838,410 patent/US5328836A/en not_active Expired - Lifetime
- 1991-07-15 ES ES91912323T patent/ES2132087T3/es not_active Expired - Lifetime
- 1991-07-15 EP EP91912323A patent/EP0539590B1/en not_active Expired - Lifetime
- 1991-07-15 DE DE69131069T patent/DE69131069T2/de not_active Expired - Fee Related
- 1991-07-15 CA CA002066618A patent/CA2066618C/en not_active Expired - Fee Related
- 1991-07-15 KR KR1019920700566A patent/KR0153009B1/ko not_active IP Right Cessation
- 1991-07-15 WO PCT/JP1991/000942 patent/WO1992001053A1/ja active IP Right Grant
- 1991-07-15 DK DK91912323T patent/DK0539590T3/da active
Also Published As
Publication number | Publication date |
---|---|
KR920702417A (ko) | 1992-09-04 |
CA2066618A1 (en) | 1992-01-14 |
EP0539590B1 (en) | 1999-03-31 |
DK0539590T3 (da) | 1999-10-11 |
ATE178354T1 (de) | 1999-04-15 |
JP2634323B2 (ja) | 1997-07-23 |
EP0539590A4 (es) | 1995-05-24 |
WO1992001053A1 (fr) | 1992-01-23 |
DE69131069D1 (de) | 1999-05-06 |
DE69131069T2 (de) | 1999-07-15 |
EP0539590A1 (en) | 1993-05-05 |
US5328836A (en) | 1994-07-12 |
KR0153009B1 (ko) | 1998-10-15 |
CA2066618C (en) | 1998-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2132087T3 (es) | Plasmidios que contienen adn que codifica la secuencia de aminoacidos de tcf-ii, celulas transformadas y produccion de la sustancia fisiologicamente activa usando las mismas. | |
AR241314A1 (es) | Aislado de adn, vector en base en dicho aislado cultivo de celulas tratadas con dicho vector y preparacion de factor viii humano funcional. | |
ES2054638T3 (es) | Gen codificante de los factores humanos de estimulacion colonial. | |
Mansilla et al. | Cadaveric bone marrow mesenchymal stem cells: first experience treating a patient with large severe burns | |
ATE192500T1 (de) | Rekombinante viren vektoren zur expression in muskelzellen | |
GT198277746A (es) | Interteron inmune humano | |
Breitfeld et al. | Expression and analysis of the polymeric immunoglobulin receptor in Madin—Darby canine kidney cells using retroviral vectors | |
BE902119A (fr) | Polypeptide physiologiquement actif humain, acide desoxyribonucleique comprenant une sequence de base codant ce polypeptide, procede de production de ce polypeptide, et composition pharmaceutique le contenant. | |
JPH0615559B2 (ja) | 心房ペプチド | |
IT1269989B (it) | Antagonisti recettoriali di il-1 ad aumentata attivita' inibitoria | |
ES2147720T3 (es) | Factor de celulas madre. | |
ES2134187T3 (es) | Preparaciones farmaceuticas. | |
EP1493754A4 (en) | POLYSACCHARIDE CONTAINING PHOSPHORYLCHOLINE GROUP AND PROCESS FOR PRODUCING THE SAME | |
JP2510503B2 (ja) | 脳由来細胞増殖因子 | |
DE60106002D1 (de) | Behandlung von hematopoietischen zellen mit cxcr4 agonisten | |
Gelher et al. | The sequence of an atriopeptigen: a precursor of the bioactive atrial peptides | |
Eming et al. | Gene therapy for tissue repair: approaches and prospects | |
CN114316030B (zh) | 一种透皮吸收性的i型重组胶原蛋白及其用途 | |
AR246310A1 (es) | Procedimiento para la preparacion de la cadena alfa- del receptor de la interleucina 5 humana, o partes del mismo, secuencia del adn, vector y celula hospedante. | |
ES2130415T3 (es) | Linfocitos t tumoricidas. | |
HADLEY et al. | Linear and Cyclic α‐Melanotropin [4–10]‐Fragment Analogues That Exhibit Superpotency and Residual Activity | |
CN109320591A (zh) | 一种多肽oa-gl12及其应用 | |
CN101875699A (zh) | 人表皮生长因子和金属硫蛋白的融合蛋白及其制备方法和应用 | |
DE69910809D1 (de) | Verwendung von OmpA Enterobakterproteinen um zielgerichtet Antigen-Präsentierende Zellen anzusteuern | |
ES2059401T3 (es) | Procedimiento microbiologico para la obtencion de una proteina mediante cultivo de una cepa bacteriana mutante. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 539590 Country of ref document: ES |